National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
NCT Number: NCT00965679
Background:
* Computed tomography (CT) creates three-dimensional images based on X-ray imaging. CT is useful for determining treatment approaches for certain diseases, such as calcific aortic stenosis (narrowing of the aorta because of calcium deposits). * Comparing the data received from CT scans with the data received from heart catheterization (which assesses the heart's condition and function) can be used to improve treatment in patients with certain heart conditions. Researchers are interested in looking at the effectiveness of both procedures in assessing possible surgical treatments for patients with calcific aortic stenosis.
Objectives:
- To analyze cardiac CT scans in conjunction with existing heart scan results to improve treatments for future minimally invasive aortic valve replacement.
Eligibility:
- Patients 18 years of age and older who have been diagnosed with aortic valve stenosis that may be treated surgically, and who will undergo or have recently undergone heart catheterization.
Design:
* Participants will have a CT scan within 90 days of the medically necessary heart catheterization, but before any other surgical or catheter treatment. * During the CT scan, patients will be asked to hold their breath intermittently for about 5 to 20 seconds. Patients will be inside the scanner for less than 30 minutes. * Patients will be asked to return in 3 to 7 days for a blood test to check kidney function. * Researchers will analyze the results of the CT scan in conjunction with the previous results from the catheterization to determine possible improved treatment options.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bethesda, Maryland, 20892, United States
We will collect cardiac computed tomography (CT) data from patients with aortic valve stenosis being considered for surgical or catheter treatment. These data will be analyzed along with medically-necessary fluoroscopy from cardiac catheterization to learn whether they can be combined to enhance future minimally invasive valve treatments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
SELECTION CRITERIA: PATHWAY FOR RESEARCH CT:
ALTERNATIVE SELECTION CRITERIA: PATHWAY FOR ANALYSIS OF MEDICAL DATA:
Exclusion criteria
SELECTION CRITERIA: PATHWAY FOR RESEARCH CT:
Exclusion criteria
FOR BETA ADRENERGIC BLOCKERS:
Exclusion criteria
FOR IODINATED RADIOCONTRAST:
-Severe kidney disease (MDRD estimated Glomerular Filtration Rate
< 30mL/min/l.73m(2)).
-Request of referring physician or surgeon not to administer iodinated radiocontrast
ALTERNATIVE SELECTION CRITERIA: PATHWAY FOR ANALYSIS OF MEDICAL DATA:
-None
National Heart, Lung, and Blood Institute (NHLBI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02729519
Aortic Valve Disease, Aortic Valve Stenosis
Montpellier, France
View Trial DetailsNCT07605780
Aortic Valve Disease, Aortic Valve Stenosis
Brescia, BS, Italy
View Trial DetailsNCT06171802
Aortic Valve Disease, Aortic Valve Stenosis
Copenhagen, Denmark
View Trial DetailsNCT05774691
Aortic Valve Disease, Aortic Valve Stenosis
Aalst, Belgium
View Trial Details